What are the likely causes and recommended treatment for an intertriginous rash beneath the breast?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rash Under Breast: Diagnosis and Management

Immediate Priority: Exclude Malignancy First

Before treating any intertriginous rash under the breast, you must first rule out inflammatory breast cancer (IBC) and Paget's disease through immediate bilateral diagnostic mammography with ultrasound. 1, 2

Red Flags Requiring Urgent Imaging

Obtain bilateral diagnostic mammography with ultrasound immediately if any of the following are present: 1, 2

  • Rapid onset of symptoms (within 6 months or less) 3, 1
  • Erythema covering ≥ one-third of the breast with or without a palpable mass 3, 1
  • Peau d'orange (skin dimpling resembling orange peel) or skin thickening 3, 2
  • Warmth of the affected breast 3, 1
  • Palpable border to the erythema 3, 1
  • Nipple changes: excoriation, scaling, bleeding, ulceration, or eczema-like appearance 1, 4
  • Failure to respond to 1 week of antibiotics if previously treated 3

Critical Pitfall to Avoid

Never initiate empiric antibiotic or topical steroid treatment without first obtaining imaging when clinical features raise suspicion for malignancy. 1, 2 IBC accounts for 1-6% of breast cancers and carries significant mortality if diagnosis is delayed. 1, 2

Biopsy Strategy When Malignancy Is Suspected

If imaging shows BI-RADS 1-3 (benign-appearing) but clinical suspicion persists:

  • Perform punch biopsy of affected skin (minimum two specimens) 1, 4
  • A negative mammogram does not exclude Paget's disease 4

If imaging shows BI-RADS 4-5 (suspicious):

  • Core needle biopsy of any breast mass is preferred, with optional skin punch biopsy 1, 4

Management of Benign Intertriginous Dermatitis

Once malignancy has been excluded through appropriate imaging, proceed with treatment of intertrigo.

Pathophysiology

Intertrigo is a superficial inflammatory dermatitis caused by skin-on-skin friction, moisture entrapment, and lack of ventilation in opposing skin folds. 5, 6 The inframammary fold is a common site, particularly in obese patients, those with diabetes, and in hot/humid conditions. 7, 8

Clinical Presentation

Physical examination reveals erythema with peripheral scaling in the skin fold. 5 Secondary infections are common due to the moist, macerated environment. 5, 6

Treatment Algorithm

Step 1: Identify and Correct Predisposing Factors

  • Weight loss in obese patients 7
  • Optimize diabetes control if present 7
  • Address immunosuppressive conditions 7
  • Treat intestinal colonization or periorificial candidal infections in recurrent cases 7

Step 2: General Skin Care Measures

  • Minimize moisture and friction with absorptive powders (cornstarch) or barrier creams 6
  • Wear light, nonconstricting, absorbent clothing; avoid wool and synthetic fibers 6
  • Shower after physical activity and dry intertriginous areas thoroughly 6
  • Avoid excessive heat and humidity 6

Step 3: Topical Antifungal Therapy (First-Line)

Candidal intertrigo is the most common secondary infection and should be treated empirically: 5

  • Topical azoles: clotrimazole, ketoconazole, oxiconazole, or econazole applied twice daily 5
  • Topical nystatin is an alternative 5
  • Diagnosis can be confirmed with potassium hydroxide (KOH) preparation showing satellite lesions 5

Step 4: Treat Secondary Bacterial Infections

If bacterial superinfection is suspected (painful lesions, yellow crusts, discharge, failure to respond to antifungals): 5

  • Streptococcal infections: topical mupirocin or oral penicillin 5
  • Corynebacterium minutissimum (erythrasma): oral erythromycin 5
  • Confirm with bacterial culture or Wood lamp examination (coral-red fluorescence suggests erythrasma) 5

Step 5: Resistant or Recurrent Cases

For cases that fail topical therapy: 7

  • Oral fluconazole for resistant candidal intertrigo 7, 5
  • Systemic antifungals with higher potency if immunosuppression or generalized infection is present 7
  • Consider advanced laboratory testing to establish differential diagnosis 7

Key Clinical Pearls

  • Bilateral involvement does NOT rule out malignancy—both IBC and Paget's disease can present bilaterally. 1
  • Ultrasound is mandatory, not optional—mammography alone is insufficient to exclude underlying masses, fluid collections, or lymph node involvement. 1, 2
  • Candidal intertrigo is diagnosed clinically by characteristic satellite lesions and can be confirmed with KOH prep. 5
  • Recurrence is common without addressing predisposing factors such as obesity, diabetes, and moisture control. 7, 8

References

Guideline

Evaluation and Management of Bilateral Superficial Breast Erythema and Pruritus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Differential Diagnosis for Sudden Thick, Leathery Skin Between the Breasts

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Testing for Paget's Disease of the Breast

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Intertrigo and secondary skin infections.

American family physician, 2014

Research

Intertrigo and common secondary skin infections.

American family physician, 2005

Research

Recurrent candidal intertrigo: challenges and solutions.

Clinical, cosmetic and investigational dermatology, 2018

Research

Intertrigo: causes, prevention and management.

British journal of nursing (Mark Allen Publishing), 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.